Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Satolli

Showing results (71-80 of 87) with videos related to

Pageof 9
Sort By:
Open Access Macedonian Journal of Medical Sciences|February 13, 2019
Using Patch Testing to Improve Therapeutic Outcome in the Treatment of Hand Eczema in Vietnamese PatientsPhuong Pham Thi Minh, Trang Trinh Minh, Doanh Le Huu, et al.
Open Access Macedonian Journal of Medical Sciences|February 13, 2019
Successful Psoriasis Treatment Using NB-UVB with Methotrexate: The Vietnamese ExperienceEm Dang Van, Thuy Pham Diem, Van Bui Thi, et al.
Journal of Clinical Medicine|June 12, 2026
Efficacy of Bimekizumab on Palmoplantar Psoriasis: A 16-Week Multicenter Retrospective Study-IL PSO (Italian Landscape PSOriasis)Martina Burlando, Lidia Sacchelli, Alberta Bettacchi, et al.
Clinical and Experimental Dermatology|June 16, 2025
Psoriasis vulgaris in patients with a recent history of neoplasia: safety of interleukin-23 inhibitors. A multicentre retrospective studyFrancesca Satolli, Silvia Gerosa, Martina Burlando, et al.
Open Access Macedonian Journal of Medical Sciences|February 13, 2019
The Efficacy of a Two-Fold Increase of H1-Antihistamine in the Treatment of Chronic Urticaria - the Vietnamese ExperienceHuyen Tran Thi, Lan Pham Thi, Thuong Nguyen Van, et al.
Dermatology and Therapy|February 19, 2026
Psychological Well-Being of Patients with Moderate-to-Severe Plaque Psoriasis Treated with Tildrakizumab: 28-Week Interim Results from a Multicenter Observational Study in Italy Using the DASS-21 Questionnaire, the BLUE StudyEmanuele Trovato, Claudio Bonifati, Simone Ribero, et al.
Dermatology and Therapy|February 16, 2026
Real-World Efficacy of IL-23 Inhibitors in Psoriasis Affecting High-Impact Areas: Indirect Comparison of Tildrakizumab 200 mg, Risankizumab, and Guselkumab-IL PSO (Italian Landscape Psoriasis)Emanuele Trovato, Alessandra Cartocci, Francesca Gaiani, et al.
Journal of Cutaneous Medicine and Surgery|March 17, 2026
Long-Term Outcomes of Secukinumab in Moderate-to-Severe Hidradenitis Suppurativa: A Multicentre Cohort StudyGianluca Avallone, Gabriele Roccuzzo, Luca Valtellini, et al.
Dermatology Practical & Conceptual|March 30, 2026
CORONATE: A Novel Questionnaire to Assess the Long-Term Impact of Psoriasis on Patients' LivesStefano Piaserico, Francesca Sampogna, Martina Accorinti, et al.
Acta Dermato-Venereologica|April 15, 2026
Efficacy and Safety of Abrocitinib for Moderate-to-severe Atopic Dermatitis in Adults: A 52-week Real-world Multicentre StudyIL-AD (Italian Landscape Atopic Dermatitis)Elena Pezzolo, Rossi Mariateresa, Raul Armando Luyo Saboya, et al.
Pageof 9

Showing results (71-80 of 87) with videos related to

Sort By:
Pageof 9
Open Access Macedonian Journal of Medical Sciences|February 13, 2019
Using Patch Testing to Improve Therapeutic Outcome in the Treatment of Hand Eczema in Vietnamese PatientsPhuong Pham Thi Minh, Trang Trinh Minh, Doanh Le Huu, et al.
Open Access Macedonian Journal of Medical Sciences|February 13, 2019
Successful Psoriasis Treatment Using NB-UVB with Methotrexate: The Vietnamese ExperienceEm Dang Van, Thuy Pham Diem, Van Bui Thi, et al.
Journal of Clinical Medicine|June 12, 2026
Efficacy of Bimekizumab on Palmoplantar Psoriasis: A 16-Week Multicenter Retrospective Study-IL PSO (Italian Landscape PSOriasis)Martina Burlando, Lidia Sacchelli, Alberta Bettacchi, et al.
Clinical and Experimental Dermatology|June 16, 2025
Psoriasis vulgaris in patients with a recent history of neoplasia: safety of interleukin-23 inhibitors. A multicentre retrospective studyFrancesca Satolli, Silvia Gerosa, Martina Burlando, et al.
Open Access Macedonian Journal of Medical Sciences|February 13, 2019
The Efficacy of a Two-Fold Increase of H1-Antihistamine in the Treatment of Chronic Urticaria - the Vietnamese ExperienceHuyen Tran Thi, Lan Pham Thi, Thuong Nguyen Van, et al.
Dermatology and Therapy|February 19, 2026
Psychological Well-Being of Patients with Moderate-to-Severe Plaque Psoriasis Treated with Tildrakizumab: 28-Week Interim Results from a Multicenter Observational Study in Italy Using the DASS-21 Questionnaire, the BLUE StudyEmanuele Trovato, Claudio Bonifati, Simone Ribero, et al.
Dermatology and Therapy|February 16, 2026
Real-World Efficacy of IL-23 Inhibitors in Psoriasis Affecting High-Impact Areas: Indirect Comparison of Tildrakizumab 200 mg, Risankizumab, and Guselkumab-IL PSO (Italian Landscape Psoriasis)Emanuele Trovato, Alessandra Cartocci, Francesca Gaiani, et al.
Journal of Cutaneous Medicine and Surgery|March 17, 2026
Long-Term Outcomes of Secukinumab in Moderate-to-Severe Hidradenitis Suppurativa: A Multicentre Cohort StudyGianluca Avallone, Gabriele Roccuzzo, Luca Valtellini, et al.
Dermatology Practical & Conceptual|March 30, 2026
CORONATE: A Novel Questionnaire to Assess the Long-Term Impact of Psoriasis on Patients' LivesStefano Piaserico, Francesca Sampogna, Martina Accorinti, et al.
Acta Dermato-Venereologica|April 15, 2026
Efficacy and Safety of Abrocitinib for Moderate-to-severe Atopic Dermatitis in Adults: A 52-week Real-world Multicentre StudyIL-AD (Italian Landscape Atopic Dermatitis)Elena Pezzolo, Rossi Mariateresa, Raul Armando Luyo Saboya, et al.
Pageof 9